The undiscovered genomic variation of an iconic fish species

The undiscovered genomic variation of an iconic fish species
Like

Why study Atlantic salmon? Because as far as fish go, they are as important and iconic as it gets. These fish have huge commercial significance and also represent keystone species in natural ecosystems, making the conservation of wild populations of major societal value. Salmonids also have an interesting and complicated genome, having gone through a whole genome duplication quite recently (well… 95 million years ago!).

Picture of a wild Atlantic salmon (salmo salar) captured in the Baltic Sea. Photo credit: Jörgen Wiklund

With over 5,000 studies published on Atlantic salmon, none had yet attempted to define structural variants (SVs, e.g. DNA deletions, duplications and inversions) across the genome. SVs can impact the function and regulation of genes, influencing normal phenotypic variation and being causative of a range of human diseases. Despite growing recognition of their importance, finding real SVs using widely available genome resequencing data remains (really!) difficult: there is a very high rate of false detection, meaning that distinguishing true calls from ‘bioinformatic garbage’ is challenging. This is one key reason why SVs are considerably understudied compared to SNPs.

Close-up photo of an Atlantic salmon in the Tana river, that forms the border between Finland and Norway. Photo credit: Panu Orell 

In our study (click here), we set out to identify SVs in Atlantic salmon by resequencing the genomes of 492 fish from diverse wild and farmed populations. This was a large effort, involving many great international collaborators. The hardest part was finding real SVs. In a series of disappointing false calls and failed attempts at bioinformatically filtering out bad data, we realised no filtering step provided high enough accuracy. With the help of computer scientist, and human SV expert, Ryan Layer (CU Boulder) we added the crucial step of visualising the calls to retain only high confidence ones. To achieve our final dataset, we manually scored 165,116 different SV calls, 90% of which were dropped. A tool called SV-plaudit made the job efficient while working in a small team. We proved the accuracy of this visual validation step using long-read sequencing and hope it will help reduce the time-consuming and costly step of validating calls in the laboratory in future studies.

Series of SV-plaudit plots. These were validated visually one by one.

Once the above crucial work was achieved, we investigated the biological role of 15,843 novel variants in Atlantic salmon. We found that many overlapped coding genes, some with large, predicted effects and evidence that the accumulation of deletions was aided by ancestral genome duplication. We also identified a mobile element that may still be active in salmon genomes. Interestingly, many SVs were found within or near brain-expressed genes involved in behaviour. Farmed salmon populations have accumulated more of these alleles in their genome and were already known to show different behaviours to their wild relatives. These genes are linked to many neurological conditions in humans and we speculate that domestication selection on linked SVs has helped farmed fish to adapt behaviourally to aquaculture conditions.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Ecology
Life Sciences > Biological Sciences > Ecology

Related Collections

With collections, you can get published faster and increase your visibility.

Pre-clinical drug discovery

We welcome studies reporting advances in the discovery, characterization and application of compounds active on biologically or industrially relevant targets. Examples include emerging screening technologies, the development of small bioactive compounds/peptides/proteins, and the elucidation of compound structure-activity relationships, target interactions and mechanism-of-action.

Publishing Model: Open Access

Deadline: Dec 31, 2023

Biomedical applications for nanotechnologies

Overall, there are still several challenges on the path to the clinical translation of nanomedicines, and we aim to bridge this gap by inviting submissions of articles that demonstrate the translational potential of nanomedicines with promising pre-clinical data.

Publishing Model: Open Access

Deadline: Dec 31, 2023